Opgenorth J, Mayorga E, Abeyta M, Goetz B, Rodriguez-Jimenez S, Freestone A
J Anim Sci. 2024; 102.
PMID: 38483214
PMC: 11034434.
DOI: 10.1093/jas/skae073.
Adda-Rezig H, Carron C, Pais de Barros J, Choubley H, Charron E, Rerole A
Front Immunol. 2021; 12:658404.
PMID: 34163471
PMC: 8215383.
DOI: 10.3389/fimmu.2021.658404.
Tamura H, Reich J, Nagaoka I
Biomedicines. 2021; 9(5).
PMID: 34064994
PMC: 8150811.
DOI: 10.3390/biomedicines9050536.
Hakoupian M, Ferino E, Jickling G, Amini H, Stamova B, Ander B
Sci Rep. 2021; 11(1):6570.
PMID: 33753837
PMC: 7985504.
DOI: 10.1038/s41598-021-86083-8.
Sali W, Patoli D, Pais de Barros J, Labbe J, Deckert V, Duheron V
Front Microbiol. 2019; 10:1774.
PMID: 31428071
PMC: 6688513.
DOI: 10.3389/fmicb.2019.01774.
Immunopharmacology of lipid A mimetics.
Bowen W, Gandhapudi S, Kolb J, Mitchell T
Adv Pharmacol. 2013; 66:81-128.
PMID: 23433456
PMC: 9536465.
DOI: 10.1016/B978-0-12-404717-4.00003-2.
Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes.
Shao B, Munford R, Kitchens R, Varley A
Innate Immun. 2012; 18(6):825-33.
PMID: 22441700
PMC: 4120711.
DOI: 10.1177/1753425912442431.
A role for intestinal alkaline phosphatase in the maintenance of local gut immunity.
Chen K, Malo M, Beasley-Topliffe L, Poelstra K, Millan J, Mostafa G
Dig Dis Sci. 2010; 56(4):1020-7.
PMID: 20844955
PMC: 3931260.
DOI: 10.1007/s10620-010-1396-x.
Apolipoprotein A-II augments monocyte responses to LPS by suppressing the inhibitory activity of LPS-binding protein.
Thompson P, Berbee J, Rensen P, Kitchens R
Innate Immun. 2008; 14(6):365-74.
PMID: 19039060
PMC: 2593401.
DOI: 10.1177/1753425908099171.
Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.
Van Amersfoort E, Van Berkel T, Kuiper J
Clin Microbiol Rev. 2003; 16(3):379-414.
PMID: 12857774
PMC: 164216.
DOI: 10.1128/CMR.16.3.379-414.2003.
Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins.
Kitchens R, Thompson P, Viriyakosol S, OKeefe G, MUNFORD R
J Clin Invest. 2001; 108(3):485-93.
PMID: 11489942
PMC: 209364.
DOI: 10.1172/JCI13139.
Distribution and kinetics of lipoprotein-bound endotoxin.
Levels J, Abraham P, van den Ende A, van Deventer S
Infect Immun. 2001; 69(5):2821-8.
PMID: 11292694
PMC: 98230.
DOI: 10.1128/IAI.69.5.2821-2828.2001.
LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction.
Vreugdenhil A, Snoek A, van t Veer C, Greve J, Buurman W
J Clin Invest. 2001; 107(2):225-34.
PMID: 11160139
PMC: 199173.
DOI: 10.1172/JCI10832.
Serum amyloid P component prevents high-density lipoprotein-mediated neutralization of lipopolysaccharide.
de Haas C, Poppelier M, van Kessel K, Van Strijp J
Infect Immun. 2000; 68(9):4954-60.
PMID: 10948110
PMC: 101709.
DOI: 10.1128/IAI.68.9.4954-4960.2000.
Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes.
Vesy C, Kitchens R, Wolfbauer G, Albers J, MUNFORD R
Infect Immun. 2000; 68(5):2410-7.
PMID: 10768924
PMC: 97439.
DOI: 10.1128/IAI.68.5.2410-2417.2000.
Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo.
Rensen P, Oosten M, Bilt E, Eck M, Kuiper J, Berkel T
J Clin Invest. 1997; 99(10):2438-45.
PMID: 9153287
PMC: 508084.
DOI: 10.1172/JCI119427.
Distribution of bacterial endotoxin in human and rabbit blood and effects of stroma-free hemoglobin.
Roth R, LEVIN F, Levin J
Infect Immun. 1993; 61(8):3209-15.
PMID: 8335351
PMC: 280989.
DOI: 10.1128/iai.61.8.3209-3215.1993.
In vivo protection against endotoxin by plasma high density lipoprotein.
Levine D, Parker T, Donnelly T, Walsh A, RUBIN A
Proc Natl Acad Sci U S A. 1993; 90(24):12040-4.
PMID: 8265667
PMC: 48121.
DOI: 10.1073/pnas.90.24.12040.
Role of the physical state of Salmonella lipopolysaccharide in expression of biological and endotoxic properties.
Shnyra A, Hultenby K, Lindberg A
Infect Immun. 1993; 61(12):5351-60.
PMID: 8225609
PMC: 281322.
DOI: 10.1128/iai.61.12.5351-5360.1993.
Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I.
Flegel W, Baumstark M, Weinstock C, Berg A, Northoff H
Infect Immun. 1993; 61(12):5140-6.
PMID: 8225591
PMC: 281294.
DOI: 10.1128/iai.61.12.5140-5146.1993.